NeuroVasc Technologies, Inc.
Mechanical thrombectomy devices for acute ischemic stroke treatment
Follows are private to you and power your alerts
Updated · neurovasctechnologies.com
- Sector
- Medtech
- Headquarters
- LAGUNA HILLS, CA
- Founded
- 2015
- Latest Form D
- $4.2M, May 2018
- Total capital
- $7.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $7.1M
- 4 Form D · last May 2018
- 102 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 8
- 8 pending · first 2018
- Rank in peer group#229 of 1112
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$4.2M
- Private capital raisedForm D · SEC · 3rd filing$500K
- Private capital raisedForm D · SEC · 2nd filing$1M
- Private capital raisedForm D · SEC · 1st filing$1.4M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1112 peers
Line = medianMedtech · Device
- Granted patents#229 · top 21%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- JIANLU MaResearcherExecutive Officer, DirectorLinked by 4 patents
- Michael LosordoResearcherExecutive OfficerLinked by 4 patents
- DAVE FERRERADirectorNamed in SEC Form D filings
- Gang LuDirectorNamed in SEC Form D filings
- James HanDirectorNamed in SEC Form D filings
- JEFF PETERSDirectorNamed in SEC Form D filings
Show all 8 people
- LU GANGDirectorNamed in SEC Form D filings
- William DaiDirectorNamed in SEC Form D filings
What it has protected
USPTO · 8 granted of 16- GrantedClot Retrieval Device for Ischemic Stroke TreatmentUSPTOUS 12,446,906
- GrantedEmbolus Removal Device with Blood Flow Restriction and Related MethodsUSPTOUS 12,059,163
- GrantedClot Retrieval Device for Ischemic Stroke TreatmentUSPTOUS 11,871,947
Show all 16 patent records
- Clot Retrieval Device for Ischemic Stroke TreatmentOct 21, 2025 · US 12,446,906Granted
- Embolus Removal Device with Blood Flow Restriction and Related MethodsAug 13, 2024 · US 12,059,163Granted
- Clot Retrieval Device for Ischemic Stroke TreatmentJan 16, 2024 · US 11,871,947Granted
- Flow Protection Device For Ischemic Stroke TreatmentJan 27, 2022 · Application 17496119Pending
- Embolus Removal Device with Blood Flow Restriction and Related MethodsJan 6, 2022 · Application 17475178Pending
- Embolus Removal Device With Blood Flow Restriction And Related MethodsSep 21, 2021 · US 11,123,089Granted
- Embolus Removal Device with Blood Flow Restriction and Related MethodsNov 17, 2020 · US 10,835,271Granted
- Clot Retrieval Device for Ischemic Stroke TreatmentAug 18, 2020 · US 10,743,895Granted
- Flow Protection Device For Ischemic Stroke TreatmentSep 12, 2019 · Application 16351248Pending
- Embolus Removal Device with Blood Flow Restriction and Related MethodsSep 11, 2018 · US 10,070,878Granted
- Clot Retrieval Device for Ischemic Stroke TreatmentJun 12, 2018 · US 9,993,257Granted
- Embolus Removal Device with Blood Flow Restriction and Related MethodsMay 4, 2017 · Application 15294709Pending
- Embolus Removal Device with Blood Flow Restriction and Related MethodsMay 4, 2017 · Application 15294708Pending
- Embolus Removal Device With Blood Flow Restriction And Related MethodsApplication PCTUS2016057244Pending
- Clot Retrieval Device For Ischemic Stroke TreatmentApplication PCTUS2017049155Pending
- Flow Protection Device For Ischemic Stroke TreatmentApplication PCTUS2019021901Pending
Related companies, and why
- Applied UV, Inc.Similar federal contract value in Medtech · null in contracts
- Ovala, Inc.Similar federal contract value in Medtech · null in contracts
- ExPrimary, Inc.Similar federal contract value in Medtech · null in contracts
- Amplifyer Bio, Inc.Similar federal contract value in Medtech · null in contracts
- EyeNetra, Inc.Similar federal contract value in Medtech · null in contracts
- InSitu Biologics, IncSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .